These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37870454)

  • 1. FusionNeoAntigen: a resource of fusion gene-specific neoantigens.
    Kumar H; Luo R; Wen J; Yang C; Zhou X; Kim P
    Nucleic Acids Res; 2024 Jan; 52(D1):D1276-D1288. PubMed ID: 37870454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene fusion neoantigens: Emerging targets for cancer immunotherapy.
    Wang Y; Shi T; Song X; Liu B; Wei J
    Cancer Lett; 2021 May; 506():45-54. PubMed ID: 33675984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis.
    Turajlic S; Litchfield K; Xu H; Rosenthal R; McGranahan N; Reading JL; Wong YNS; Rowan A; Kanu N; Al Bakir M; Chambers T; Salgado R; Savas P; Loi S; Birkbak NJ; Sansregret L; Gore M; Larkin J; Quezada SA; Swanton C
    Lancet Oncol; 2017 Aug; 18(8):1009-1021. PubMed ID: 28694034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sources of Cancer Neoantigens beyond Single-Nucleotide Variants.
    Capietto AH; Hoshyar R; Delamarre L
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.
    Schrörs B; Lübcke S; Lennerz V; Fatho M; Bicker A; Wölfel C; Derigs P; Hankeln T; Schadendorf D; Paschen A; Wölfel T
    Oncotarget; 2017 Apr; 8(17):28312-28327. PubMed ID: 28423700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors.
    Shi Y; Jing B; Xi R
    Genome Biol; 2023 Jul; 24(1):169. PubMed ID: 37461029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoantigens: promising targets for cancer therapy.
    Xie N; Shen G; Gao W; Huang Z; Huang C; Fu L
    Signal Transduct Target Ther; 2023 Jan; 8(1):9. PubMed ID: 36604431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A library of Neo Open Reading Frame peptides (NOPs) as a sustainable resource of common neoantigens in up to 50% of cancer patients.
    Koster J; Plasterk RHA
    Sci Rep; 2019 Apr; 9(1):6577. PubMed ID: 31036835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoantigen identification: Technological advances and challenges.
    Pu T; Peddle A; Zhu J; Tejpar S; Verbandt S
    Methods Cell Biol; 2024; 183():265-302. PubMed ID: 38548414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GNIFdb: a neoantigen intrinsic feature database for glioma.
    Li W; Sun T; Li M; He Y; Li L; Wang L; Wang H; Li J; Wen H; Liu Y; Chen Y; Fan Y; Xin B; Zhang J
    Database (Oxford); 2022 Feb; 2022():. PubMed ID: 35150127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ScanNeo2: a comprehensive workflow for neoantigen detection and immunogenicity prediction from diverse genomic and transcriptomic alterations.
    Schäfer RA; Guo Q; Yang R
    Bioinformatics; 2023 Nov; 39(11):. PubMed ID: 37882750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic neoantigens derived from gene fusions stimulate T cell responses.
    Yang W; Lee KW; Srivastava RM; Kuo F; Krishna C; Chowell D; Makarov V; Hoen D; Dalin MG; Wexler L; Ghossein R; Katabi N; Nadeem Z; Cohen MA; Tian SK; Robine N; Arora K; Geiger H; Agius P; Bouvier N; Huberman K; Vanness K; Havel JJ; Sims JS; Samstein RM; Mandal R; Tepe J; Ganly I; Ho AL; Riaz N; Wong RJ; Shukla N; Chan TA; Morris LGT
    Nat Med; 2019 May; 25(5):767-775. PubMed ID: 31011208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoantigens in Hematological Malignancies-Ultimate Targets for Immunotherapy?
    Roerden M; Nelde A; Walz JS
    Front Immunol; 2019; 10():3004. PubMed ID: 31921218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing gene fusion-derived neoantigens for 'cold' breast and prostate tumor immunotherapy.
    Velaga R; Koo KM; Mainwaring PN
    Immunotherapy; 2022 Oct; 14(14):1165-1179. PubMed ID: 36043380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Best practices for bioinformatic characterization of neoantigens for clinical utility.
    Richters MM; Xia H; Campbell KM; Gillanders WE; Griffith OL; Griffith M
    Genome Med; 2019 Aug; 11(1):56. PubMed ID: 31462330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MONET: a database for prediction of neoantigens derived from microsatellite loci.
    Deng N; Sinha KM; Vilar E
    Front Immunol; 2024; 15():1394593. PubMed ID: 38835776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoantigen landscape in metastatic nasopharyngeal carcinoma.
    Lin M; Zhang XL; You R; Yang Q; Zou X; Yu K; Liu YP; Zou RH; Hua YJ; Huang PY; Wang J; Zhao Q; Jiang XB; Tang J; Gu YK; Yu T; He GP; Xie YL; Wang ZQ; Liu T; Chen SY; Zuo ZX; Chen MY
    Theranostics; 2021; 11(13):6427-6444. PubMed ID: 33995666
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.
    Bai P; Li Y; Zhou Q; Xia J; Wei PC; Deng H; Wu M; Chan SK; Kappler JW; Zhou Y; Tran E; Marrack P; Yin L
    Oncoimmunology; 2021 Jan; 10(1):1868130. PubMed ID: 33537173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of shared neoantigens in esophageal carcinoma by the combination of comprehensive analysis of genomic data and in silico neoantigen prediction.
    Yuan Y; Chen C; Liu S; Xiong H; Huang Y; Zhang X; Zhang X; Li B
    Cell Immunol; 2022 Jul; 377():104537. PubMed ID: 35636066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of CD8
    Shinkawa T; Tokita S; Nakatsugawa M; Kikuchi Y; Kanaseki T; Torigoe T
    Oncoimmunology; 2021 Jan; 10(1):1870062. PubMed ID: 33537174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.